###### Strengths and limitations of this study

-   The questionnaire was developed using content validity reduction and factor analysis of a consensus item pool, and therefore grounded in primary care practitioners\' (PCPs') clinical experience.

-   PCPs were recruited from 20 European countries, 4 countries from each of the Central, Eastern, Northern, Southern and Western European geographical areas.

-   Most samples were taken from each local lead's own locality, and these may not have been representative of their nations as a whole.

-   The response rate was low but comparable to that of other equivalent surveys of primary care doctors.

Background {#s1}
==========

There is wide variation in cancer survival rates across Europe.[@R1] Data from the fifth cycle of the European Cancer Registry-based Study on Survival and Care of Cancer Patients (EUROCARE-5) show that the 1-year relative survival rate for all cancer sites varies from 58.2% to 81.1% between countries[@R1] ([table 1](#T1){ref-type="table"}). Although 1-year relative survival can be affected by differences in registration (eg, completeness and use of death certificates), and lead-time and overdiagnosis biases,[@R2] it is generally taken to be an indicator of more advanced disease at diagnosis.[@R4] Survival differences in the subsequent 4-year period (known as '5\|1-year conditional survival') are narrower, suggesting that earlier diagnosis could reduce the 1-year relative survival gap.[@R6] This is supported by increasing evidence that longer time to diagnosis and treatment may adversely affect mortality.[@R7] While recent overall cancer survival trends show improvements,[@R14] there is little narrowing in the between-country survival differences.[@R15]

###### 

EUROCARE-5 1-year relative and 5\|1-year conditional cancer survival rates for European countries,[@R1] with ranks given

  Country            1-year relative survival (%)   1-year relative survival: rank   5\|1-year conditional survival (%)   5\|1-year conditional survival: rank
  ------------------ ------------------------------ -------------------------------- ------------------------------------ --------------------------------------
  Austria            75.9                           11                               60.1                                 7
  Belgium            78.9                           3                                60.4                                 6
  Bulgaria           58.2                           28                               38.7                                 28
  Croatia            62.1                           25                               46.2                                 22
  Czech Republic     68.3                           19                               50.7                                 19
  Denmark            69.8                           18                               50.9                                 18
  Estonia            65.9                           22                               46.0                                 24
  Finland            76.9                           8                                61.4                                 4
  France             77.8                           7                                58.6                                 10
  Germany            76.7                           9                                59.1                                 9
  Greece             (not available)                (not available)                                                       
  Iceland            78.3                           6                                61.2                                 5
  Ireland            70.3                           16                               54.0                                 15
  Israel (Arabs)\*   78.6                           4                                61.4                                 3
  Israel (Jews)\*    82.8                           1                                68.9                                 1
  Italy              74.9                           12                               56.8                                 12
  Latvia             60.9                           27                               41.7                                 26
  Lithuania          63.8                           24                               46.1                                 23
  Malta              70.0                           17                               52.9                                 16
  Netherlands        73.0                           14                               54.6                                 14
  Norway             76.1                           10                               58.6                                 11
  Poland             61.7                           26                               40.6                                 27
  Portugal           74.0                           13                               56.4                                 13
  Romania            (not available)                (not available)                                                       
  Slovakia           65.4                           23                               44.8                                 25
  Slovenia           67.7                           21                               47.8                                 21
  Spain              71.5                           15                               52.8                                 17
  Sweden             81.1                           2                                64.8                                 2
  Switzerland        78.3                           5                                59.2                                 8
  UK                 67.9                           20                               50.1                                 20
  European mean      72.5                                                            54.2                                 

\*Calculated from data provided by B Silverman, Israel Ministry of Health (personal communication, 7 September 2017).

The challenge of where and how to achieve more timely diagnosis is considerable.[@R16] A general practitioner (GP) will see only a small number of new cancers each year, for example, a GP in the United Kingdom (UK) will on average have a new cancer diagnosed in one of his or her patients each month.[@R17] The majority of cancers are identified because the patient has been experiencing symptoms. However, most patients present with evolving and undifferentiated symptoms that are much more likely to be interpreted as something other than cancer.[@R16]

GP gatekeeping, in which patients' access to specialists, hospital care and diagnostic tests needs to be authorised by GPs,[@R18] is the cornerstone of many European medical systems.[@R19] There is evidence that stronger gatekeeper systems are linked with lower 1-year relative cancer survival than systems without such gatekeeper functions.[@R20] This may be because gatekeeping systems can impose cost and resource decisions which impede early referral for investigation.[@R21] However, there are wide variations in the degree of gatekeeping between countries, with no simple binary model as to whether or not a country has a 'GP-as-gatekeeper' system, and a European study found no link between a higher probability of initial consultation with a GP and poorer cancer survival.[@R22]

The way in which different healthcare systems support primary care in cancer diagnosis by quick and easy access to investigations may also be a factor in timeliness of cancer diagnosis.[@R23] It has been suggested that GPs need faster routes to diagnostic tests and/or specialist opinion for all patients with a suspicious symptom, above a certain threshold.[@R21] In the UK, use of an urgent cancer referral pathway has been found to be associated with reduced mortality[@R24] and a reduction in the proportion of cancers diagnosed through emergency presentations.[@R25] An International Cancer Benchmarking Partnership (ICBP) study demonstrated a correlation between the readiness of primary care practitioners (PCPs) to investigate suspicious symptoms and cancer survival rates.[@R26] No consistent associations were found between how likely practitioners were to investigate and PCP demographics, practice or health system variables. However, there was no exploration of how individual doctors felt that health system factors affected their decision-making.

The Örenäs Research Group is a European group of primary care researchers that studies the primary care factors that relate to cancer survival. It has identified a large variety of non-clinical factors that are likely to have a considerable impact on PCPs' referral decision-making.[@R27] These include levels of gatekeeping responsibility, funding systems, access to investigations and relationships with specialist colleagues. However, there has been little research done to explain how these vary between countries.[@R16]

This study investigated the health system factors potentially influencing European PCPs' decision-making with regard to investigating patients who may have cancer, and how these vary between European countries.

Methods and design {#s2}
==================

Design {#s2a}
------

We performed an international online survey of PCPs in 20 European countries between November 2015 and December 2016. Some of the methodology described here reproduces information already reported in our published protocol paper.[@R28]

Development of the questionnaire {#s2b}
--------------------------------

Following a literature review, 7 Örenäs Research Group investigators developed and agreed by consensus a list of 45 items, each relating to predefined aspects/concepts that may affect a PCP's decision to refer patients with potential cancer symptoms for further investigation. A questionnaire based on these items was piloted by 16 members of the Örenäs Research Group to assess content validity. Six of the items were removed due to low content validity. An English-language questionnaire with the remaining 39 items was piloted by 49 PCPs in 16 Örenäs Research Group member countries ([table 2](#T2){ref-type="table"}). Nineteen items were found to show little or no variation between countries and were removed from the questionnaire, leaving 20 items.

###### 

Results of questionnaire pilot

  Response                                                                                                                                    Number of countries in which piloting PCPs agreed with statement   Number of countries in which piloting PCPs were unsure   Number of countries in which piloting PCPs disagreed with statement
  ------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------ -------------------------------------------------------- ---------------------------------------------------------------------
  Even if there are no 'red-flag' symptoms, we usually refer if we have a feeling that something is wrong.\*                                  11                                                                 4                                                        0
  Here, high-quality care for an individual patient is always more important than costs.                                                      5                                                                  6                                                        5
  If we have 'over-referred', our own income may be reduced.\*                                                                                1                                                                  3                                                        12
  If we organise any investigations, we pay for that themselves.\*                                                                            1                                                                  2                                                        13
  In some practices, patients often have to travel a long way to see a specialist.                                                            9                                                                  5                                                        2
  Long waiting lists for specialists or tests mean that we sometimes delay a referral/special investigation until it is really necessary.\*   1                                                                  10                                                       5
  Many primary care doctors have special investigations (eg, diagnostic ultrasound) in their practices.\*                                     1                                                                  5                                                        10
  Missing a diagnosis of cancer is something that we particularly worry about.\*                                                              15                                                                 0                                                        0
  Patients can self-refer to specialists, so we do not need to act as a gatekeeper.                                                           5                                                                  1                                                        10
  Patients sometimes criticise us if they think we delayed a cancer diagnosis because of a late referral.\*                                   13                                                                 3                                                        0
  Paying for a specialist can be a problem for some of our patients.                                                                          5                                                                  4                                                        7
  Referral costs are usually paid by insurance companies, not primary care or hospital budgets.                                               6                                                                  3                                                        7
  Referring or not referring does not affect our income at all.                                                                               10                                                                 3                                                        3
  Some of our referral systems (eg, online referral systems) make the referral process more difficult.\*                                      1                                                                  4                                                        11
  Specialists often try to reduce referrals to them.\*                                                                                        1                                                                  5                                                        10
  Specialists often welcome referrals.                                                                                                        6                                                                  7                                                        3
  Specialists sometimes criticise us if they think that a cancer diagnosis was slow because of a late referral.\*                             12                                                                 3                                                        1
  Specialists sometimes criticise us if they think that we should have been able to look after the patient ourselves.                         7                                                                  5                                                        4
  There is a special, quick specialist appointment system for patients with suspected cancer.                                                 8                                                                  3                                                        5
  Usually, patients prefer a general practitioner (rather than a specialist) to look after them.                                              6                                                                  6                                                        4
  We are asked not to refer patients with a low risk of cancer.\*                                                                             1                                                                  4                                                        11
  We are asked to refer any patients with possible cancer early, even if there is a low risk of cancer.                                       6                                                                  7                                                        3
  We are likely to refer if the patient is very worried that he/she has cancer, even if there are no 'red flag' symptoms.\*                   12                                                                 2                                                        1
  We are likely to refer if the patient says that she/he would like to be referred, even if there are no red flags.                           8                                                                  3                                                        4
  We are often worried about the risk of unnecessary (and possibly harmful) investigations.\*                                                 12                                                                 2                                                        1
  We are under media (newspaper, television) or public pressure to refer earlier.                                                             5                                                                  4                                                        6
  We are under media (newspaper, television) or public pressure to refer less.\*                                                              1                                                                  3                                                        11
  We are usually very busy, so we sometimes refer to help reduce our workload.                                                                6                                                                  5                                                        5
  We can easily email a specialist for advice.                                                                                                5                                                                  3                                                        8
  We can easily telephone a specialist for advice.                                                                                            5                                                                  5                                                        6
  We can refer directly to a named specialist.                                                                                                8                                                                  4                                                        4
  We have a budget for patient care costs, but we share it with secondary care.\*                                                             0                                                                  2                                                        14
  We have a budget or quota (maximum limit) for referrals.\*                                                                                  1                                                                  3                                                        12
  We have a budget or quota (maximum limit) for special tests.                                                                                4                                                                  2                                                        9
  We have guidelines that help us decide which patients to refer.                                                                             7                                                                  2                                                        7
  We often refer to a specialist that we know personally.                                                                                     8                                                                  6                                                        2
  We usually have enough time in the consultation to think carefully about whether the patient needs a referral.                              6                                                                  6                                                        4
  We worry about the possibility of legal action or a formal complaint if we refer late.\*                                                    8                                                                  7                                                        1
  Writing a good referral letter takes time, and as we are usually very busy we sometimes delay making a referral.\*                          1                                                                  2                                                        13

\*These statements were removed from the final questionnaire because either (a) one or no piloting countries agreed with the statement, or (b) one or no piloting countries disagreed with the statement.

Örenäs Research Group leads arranged for translations of the questionnaire into their local languages where these were not English, a total of 19 translations from the original English. Translation and validation were done in a standardised way[@R29]: native speakers of the local languages who were fluent in English and were medically qualified did the 'forward' translations. 'Backward' translations into English were then made by translators who were fluent in both English and their local language. The forward translations were then compared with the backward ones, to assess semantic and conceptual equivalence.[@R30] Discrepancies between the forward and backward translations were resolved by discussion with the translators, following which the final translation was agreed on. Finally, in each country the corrected versions were piloted in a small sample of PCPs to evaluate the instructions, response format and the items for clarity and to ensure cultural adaptation.[@R30]

The questionnaire and distribution {#s2c}
----------------------------------

The final questionnaire sought demographic information ([table 3](#T3){ref-type="table"}) and presented the 20 health system factor items (listed in [table 4](#T4){ref-type="table"}). Respondents were asked to rate how much they agreed with each item in relation to their referral decision-making for patients who could have cancer. A five-point Likert rating scale was provided for participants, with response options ranging from 'strongly disagree' to 'strongly agree'. The questionnaires were put online using SurveyMonkey. Online methodology was used to aid the logistics of survey administration; online surveys have been successfully used in research involving cancer care professionals.[@R31]

###### 

Number of respondents per country and demographic distributions.

  Country                         Number of respondents (% of all respondents)
  ------------------------------- ----------------------------------------------
   Bulgaria                       51 (2.8)
   Croatia                        56 (3.1)
   Denmark                        92 (5.0)
   England                        62 (3.4)
   Finland                        61 (3.3)
   France                         52 (2.8)
   Germany                        91 (5.0)
   Greece                         59 (3.2)
   Israel                         58 (3.2)
   Italy                          60 (3.3)
   Netherlands                    107 (5.8)
   Norway                         81 (4.4)
   Poland                         135 (7.4)
   Portugal                       59 (3.2)
   Romania                        146 (8.0)
   Scotland                       62 (3.4)
   Slovenia                       91 (5.0)
   Spain                          379 (20.7)
   Sweden                         68 (3.7)
   Switzerland                    60 (3.3)
   Total                          1830 (100)
  Respondent gender               
   Female                         1108 (60.5)
   Male                           708 (38.7)
   Not stated                     14 (0.8)
   Total                          1830 (100)
  Years since graduation          
   \<10                           284 (15.5)
   10--19                         492 (26.9)
   20--29                         535 (29.2)
   30--39                         442 (24.2)
   40 or over                     69 (3.8)
   Not stated                     8 (0.4)
   Total                          1830 (100)
  Site of practice                
   Urban                          1086 (59.6)
   Rural                          426 (23.3)
   Island                         50 (2.7)
   Mixed                          268 (14.6)
   Total                          1830 (100)
  Number of doctors in practice   
   1                              252 (13.8)
   2                              210 (11.5)
   3                              196 (10.7)
   4--5                           304 (16.6)
   6--7                           235 (12.8)
   8--9                           153 (8.4)
   10 or more                     470 (25.7)
   Not stated                     10 (0.5)
   Total                          1830 (100)

###### 

Mean national Likert-scale values for each of the 20 questions

                                                                                                                                                         Bulgaria   Croatia   Denmark   England   Finland   France   Germany   Greece   Israel   Italy   Netherlands   Norway   Poland   Portugal   Romania   Scotland   Slovenia   Spain   Sweden   Switzerland
  ------------------------------------------------------------------------------------------------------------------------------------------------------ ---------- --------- --------- --------- --------- -------- --------- -------- -------- ------- ------------- -------- -------- ---------- --------- ---------- ---------- ------- -------- -------------
  Common presentations are covered by local or national guidelines that usually give advice on which patients to refer.                                  2.76       3.22      3.96      3.92      4.00      3.04     3.35      3.59     3.64     3.40    3.96          3.26     3.44     3.12       3.37      3.89       3.73       3.90    3.59     3.37
  The local health system encourages us to refer any patients with possible cancer early, even if there is a low risk of cancer.                         2.78       3.00      3.91      3.29      2.97      3.29     3.79      3.37     3.60     3.05    2.84          3.20     3.18     2.97       3.68      3.31       3.28       3.07    2.91     4.05
  In my practice, patients often have to travel a long way to see a specialist.                                                                          1.91       2.45      2.02      2.44      1.62      1.98     1.76      3.24     2.40     2.83    1.79          1.89     2.54     1.90       2.78      2.74       2.34       1.99    2.59     1.68
  I am able to refer directly to a named specialist.                                                                                                     3.80       2.73      4.28      2.10      1.95      4.55     4.60      3.90     4.49     3.24    3.92          3.84     2.73     2.81       3.83      2.35       2.73       3.79    2.31     4.90
  I am able to refer to a specialist that I know personally.                                                                                             4.14       2.89      3.38      2.02      2.00      4.24     4.39      3.86     4.26     3.41    3.74          2.67     2.77     2.27       3.81      2.34       2.92       2.52    2.29     4.87
  I can easily telephone (or email) a specialist for informal discussion and advice.                                                                     3.36       2.52      3.68      3.16      3.90      3.80     4.21      3.07     3.82     3.13    4.18          3.25     1.69     2.71       3.25      3.23       2.51       3.39    4.04     4.73
  Here, specialists usually welcome referrals.                                                                                                           4.37       2.85      3.36      3.35      3.48      4.18     3.89      3.31     3.88     3.21    4.02          3.79     2.29     3.14       3.01      3.06       2.21       2.68    3.37     4.70
  Seeing a specialist can be a problem for some of my patients because of the financial cost to them.                                                    3.22       2.82      1.74      2.28      2.64      4.06     1.74      4.36     2.21     3.70    3.90          2.15     3.13     2.71       3.80      2.02       2.70       2.12    2.04     2.32
  We have a budget or quota (maximum limit) for diagnostic tests.                                                                                        4.36       3.02      1.68      1.87      1.92      1.60     3.18      3.63     2.21     2.44    2.03          1.34     3.52     3.22       3.09      1.51       2.88       2.72    2.07     1.35
  Here, high-quality care for an individual patient is always more important than costs.                                                                 3.20       3.53      3.95      3.85      3.77      3.75     3.23      3.51     3.91     3.48    3.76          3.59     3.38     3.95       3.87      3.89       3.74       3.67    4.03     4.08
  Referring or not referring does not affect me at all financially.                                                                                      2.69       3.13      4.41      4.07      4.20      4.67     4.18      3.68     4.33     3.31    4.28          4.46     3.52     4.29       3.99      4.43       4.04       3.63    4.26     4.27
  Referral costs are usually paid by insurance companies, not hospital or primary care budgets.                                                          2.76       3.41      1.00      1.63      1.33      2.88     3.56      2.10     2.84     1.94    4.00          1.78     2.71     1.63       3.70      1.66       4.13       1.84    1.41     4.48
  My colleagues sometimes criticise me if I have referred a patient to them, but they think that I should have been able to manage the patient myself.   2.08       2.76      1.90      2.39      2.51      2.19     1.48      2.92     2.11     2.63    2.29          2.58     3.38     2.53       2.72      2.40       3.24       2.41    2.65     1.27
  In general, patients prefer a general practitioner (GP), rather than a specialist, to look after them.                                                 3.12       3.09      3.40      3.00      2.61      3.00     3.67      3.56     3.52     3.30    3.53          2.99     2.98     3.12       3.53      3.23       3.49       3.22    3.12     3.65
  We have access to a fast-track specialist appointment system for patients with suspected cancer.                                                       2.71       3.22      4.75      4.66      4.08      3.46     2.87      2.45     3.33     3.22    4.30          4.67     3.63     3.42       2.58      4.37       3.22       4.06    3.31     2.27
  Patients can self-refer to specialists, so GPs do not need to act as gatekeepers.                                                                      2.39       2.04      1.41      1.39      1.92      2.29     3.19      2.58     3.10     2.65    1.61          1.59     1.83     1.86       2.38      1.38       1.55       1.45    2.75     3.02
  I am usually very busy, so I sometimes refer to help reduce my workload.                                                                               2.73       2.16      2.61      2.53      2.59      2.48     1.98      2.24     2.98     2.56    2.51          2.40     2.82     2.12       1.96      1.92       3.01       2.43    2.15     1.97
  I usually have enough time in the consultation to think carefully about whether the patient needs a referral.                                          3.32       3.52      3.43      3.02      3.15      3.77     3.86      3.49     3.16     3.67    3.59          3.75     2.64     2.58       3.90      3.29       2.91       2.83    3.16     3.69
  I am likely to refer if the patient says that she/he would like to be referred, even if there are no 'red flags'.                                      3.10       2.59      3.02      3.20      2.51      2.96     3.62      3.42     3.69     3.36    2.92          3.11     3.63     3.05       2.80      3.00       3.30       2.88    3.06     3.52
  We are under media (newspaper, television) or public pressure to refer earlier.                                                                        3.84       3.04      3.38      3.97      2.82      2.81     4.16      2.69     3.16     3.42    3.10          3.80     3.61     2.42       2.65      3.92       3.36       3.23    2.50     2.77

A response of 'strongly disagree' was given a score of 1; 'disagree'=2; 'neither agree nor disagree'=3; 'agree'=4; 'strongly agree'=5.

Study population {#s2d}
----------------

The study was conducted in 25 Örenäs Research Group centres in 20 countries across Europe: Bulgaria, Croatia, Denmark, England, Finland, France, Germany, Greece, Israel, Italy, Netherlands, Norway, Poland, Portugal, Romania, Scotland, Slovenia, Spain, Sweden and Switzerland. Local study leads were asked to either gain ethical approval or obtain a statement that formal ethical approval was not needed in their jurisdiction (see online [supplementary file](#SP1){ref-type="supplementary-material"}).
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Subjects were eligible for the survey if they were doctors working mainly in primary care. These doctors, here referred to collectively as 'PCPs', included GPs and other doctors who had had specialist training but worked in the community and could be accessed directly by patients without referral.

Sample size {#s2e}
-----------

A total sample size of 1000 or more responses was calculated to be sufficient to obtain stable factor estimates within the exploratory factor analysis,[@R32] based on each jurisdiction recruiting at least 50 respondents. This provided a 95% CI of at most ±14%.

Recruitment of participants {#s2f}
---------------------------

Each Örenäs Research Group local lead was asked to email an invitation to take part in the survey to the PCPs in their local health district, and to recruit at least 50 participants. In six countries (Denmark, Norway, Portugal, Romania, Slovenia, Sweden), the invitation was distributed to a national sample. Any local leads who had difficulty in achieving the required sample sizes were asked to increase the number of responses by using snowballing.[@R33] Consent was implied by agreeing to take part in the survey. All data were collected anonymously.

Statistical analysis {#s2g}
--------------------

The demographic characteristics of the respondents were explored using descriptive statistics. Likert scale responses were converted to numerical scores ('strongly disagree'=1, 'strongly agree'=5). An exploratory factor analysis was undertaken on these responses, to identify underlying factors and to test the predefined constructs.

We used a principal components method,[@R34] with a direct oblimin rotation to allow for correlated factors. The number of components was defined by inspection of the scree plot and the Kaiser criterion (eigenvalue ≥1). Between-country variation in these factors was then examined and presented as means with 95% CIs. We made a sensitivity analysis with weighting of the responses to adjust for the differing numbers of respondents per country. Calculations were performed using IBM SPSS V.22.

Patient and public involvement {#s2h}
------------------------------

There was no patient or public involvement in this study.

Results {#s3}
=======

A total of 1830 PCPs completed the questionnaire. All participating centres received at least 50 responses, with a median of 72 respondents per centre. PCPs' demographic distributions are shown in [table 3](#T3){ref-type="table"}. The median response rate per country was 20.8% (range 6.7%--57.8%).

The mean national Likert-scale values for each of the 20 questions are given in [table 4](#T4){ref-type="table"}.

The factor loadings for each of the 20 items are shown in [table 5](#T5){ref-type="table"}. The factor analysis identified five factors which accounted for 47.4% of the variance of individual responses. The factor means for each participating country and their 95% CIs are given in [table 6](#T6){ref-type="table"}.

###### 

Health system items and their factor analysis loadings The highest-scoring component for each item is italicised.

  Health system item                                                                                                                                      Component                               
  ------------------------------------------------------------------------------------------------------------------------------------------------------- ----------- --------- -------- -------- --------
  Factor 1                                                                                                                                                1           2         3        4        5
   I am able to refer to a specialist that I know personally.                                                                                             *0.68*      0.42      0.09     0.03     −0.14
   Here, specialists usually welcome referrals.                                                                                                           *0.68*      0.02      0.12     −0.04    −0.11
   I can easily telephone (or email) a specialist for informal discussion and advice.                                                                     *0.68*      −0.12     0.11     0.17     −0.12
   I am able to refer directly to a named specialist.                                                                                                     *0.62*      0.22      0.22     0.13     −0.26
   I usually have enough time in the consultation to think carefully about whether the patient needs a referral.                                          *0.57*      −0.02     −0.32    0.07     0.12
   My colleagues sometimes criticise me if I have referred a patient to them, but they think that I should have been able to manage the patient myself.   *−0.51*     0.25      0.14     0.12     0.31
  Factor 2                                                                                                                                                                                        
   Seeing a specialist can be a problem for some of my patients because of the financial cost to them.                                                    −0.08       *0.59*    −0.17    0.27     0.24
   We have access to a fast-track specialist appointment system for patients with suspected cancer.                                                       0.05        *−0.54*   0.34     0.34     −0.03
   We have a budget or quota (maximum limit) for diagnostic tests.                                                                                        −0.27       *0.54*    −0.06    0.25     −0.26
   Referral costs are usually paid by insurance companies, not hospital or primary care budgets.                                                          0.30        *0.46*    −0.05    −0.19    0.23
   Patients can self-refer to specialists, so GPs do not need to act as gatekeepers.                                                                      0.34        *0.44*    0.04     −0.30    0.11
   In my practice, patients often have to travel a long way to see a specialist.                                                                          −0.26       *0.38*    −0.09    0.37     0.36
  Factor 3                                                                                                                                                                                        
   I am usually very busy, so I sometimes refer to help reduce my workload.                                                                               −0.32       0.19      *0.60*   −0.09    −0.01
   I am likely to refer if the patient says that she/he would like to be referred, even if there are no 'red flags'.                                      −0.02       0.29      *0.53*   −0.34    0.16
   We are under media (newspaper, television) or public pressure to refer earlier.                                                                        −0.20       0.08      *0.51*   −0.09    −0.16
   The local health system encourages us to refer any patients with possible cancer early, even if there is a low risk of cancer.                         0.26        0.11      *0.36*   0.23     0.20
  Factor 4                                                                                                                                                                                        
   Common presentations are covered by local or national guidelines that usually give advice on which patients to refer                                   0.05        −0.25     0.33     *0.55*   0.15
   In general, patients prefer a GP, rather than a specialist, to look after them.                                                                        0.25        0.19      −0.02    *0.41*   0.08
  Factor 5                                                                                                                                                                                        
   Here, high-quality care for an individual patient is always more important than costs.                                                                 0.30        −0.26     0.01     0.05     *0.57*
   Referring or not referring does not affect me at all financially.                                                                                      0.31        −0.29     0.08     −0.34    *0.55*

###### 

Factor means for each country with 95% CIs

                Number of respondents   Factor 1                 Factor 2                 Factor 3                 Factor 4                 Factor 5
  ------------- ----------------------- ------------------------ ------------------------ ------------------------ ------------------------ ------------------------
  Bulgaria      52                      0.62 (0.43 to 0.82)      0.58 (0.34 to 0.82)      0.23 (−0.12 to 0.59)     −1.11 (−1.50 to −0.72)   −1.43 (−1.74 to −1.11)
  Croatia       56                      −0.47 (−0.70 to −0.24)   0.42 (0.21 to 0.62)      −0.48 (−0.74 to −0.21)   −0.46 (−0.78 to −0.14)   −0.53 (−0.81 to −0.25)
  Denmark       92                      0.39 (0.25 to 0.54)      −1.04 (−1.15 to −0.93)   0.15 (−0.04 to 0.35)     0.59 (0.43 to 0.76)      0.41 (0.26 to 0.57)
  England       62                      −0.65 (−0.85 to −0.45)   −0.90 (−1.09 to −0.71)   0.29 (0.06 to 0.51)      0.31 (0.12 to 0.50)      0.34 (0.16 to 0.52)
  Finland       61                      −0.52 (−0.70 to −0.34)   −0.83 (−0.97 to −0.68)   −0.34 (−0.59 to −0.10)   −0.07 (−0.31 to 0.17)    0.38 (0.19 to 0.56)
  France        52                      0.76 (0.57 to 0.95)      0.58 (0.41 to 0.75)      −0.23 (−0.50 to 0.04)    −0.27 (−0.51 to −0.03)   0.58 (0.42 to 0.74)
  Germany       91                      1.41 (1.26 to 1.55)      0.40 (0.22 to 0.57)      0.43 (0.25 to 0.62)      −0.64 (−0.87 to −0.42)   0.02 (−0.23 to 0.27)
  Greece        59                      0.03 (−0.18 to 0.24)     1.40 (1.21 to 1.60)      −0.21 (−0.46 to 0.03)    0.35 (0.03 to 0.67)      −0.61 (−0.86 to −0.37)
  Israel        58                      0.89 (0.73 to 1.05)      0.48 (0.29 to 0.68)      0.67 (0.39 to 0.95)      −0.05 (−0.31 to 0.21)    0.49 (0.25 to 0.72)
  Italy         60                      −0.18 (−0.44 to 0.08)    0.52 (0.32 to 0.73)      −0.07 (−0.38 to 0.25)    −0.06 (−0.34 to 0.21)    −0.45 (−0.82 to −0.09)
  Netherlands   108                     0.60 (0.50 to 0.70)      0.23 (0.12 to 0.33)      −0.24 (−0.40 to −0.08)   0.44 (0.33 to 0.55)      0.29 (0.16 to 0.41)
  Norway        81                      0.11 (−0.06 to 0.28)     −0.77 (−0.92 to −0.62)   0.16 (−0.04 to 0.36)     −0.18 (−0.35 to 0.00)    0.52 (0.36 to 0.68)
  Poland        135                     −1.00 (−1.15 to −0.84)   0.40 (0.26 to 0.55)      0.70 (0.52 to 0.88)      −0.15 (−0.36 to 0.06)    −0.59 (−0.77 to −0.40)
  Portugal      59                      −0.63 (−0.84 to −0.42)   −0.09 (−0.31 to 0.13)    −0.32 (−0.57 to −0.06)   −0.48 (−0.76 to −0.19)   0.01 (−0.20 to 0.22)
  Romania       146                     0.16 (0.01 to 0.31)      1.30 (1.17 to 1.43)      −0.69 (−0.86 to −0.52)   0.11 (−0.05 to 0.28)     −0.03 (−0.19 to 0.13)
  Scotland      62                      −0.54 (−0.72 to −0.37)   −0.71 (−0.88 to −0.53)   −0.14 (−0.33 to 0.05)    0.34 (0.14 to 0.55)      0.57 (0.39 to 0.75)
  Slovenia      91                      −0.71 (−0.87 to −0.56)   0.53 (0.40 to 0.67)      0.48 (0.30 to 0.66)      0.08 (−0.13 to 0.28)     0.01 (−0.18 to 0.20)
  Spain         380                     −0.27 (−0.35 to −0.19)   −0.67 (−0.75 to −0.60)   −0.03 (−0.13 to 0.07)    0.21 (0.12 to 0.31)      −0.36 (−0.46 to −0.26)
  Sweden        68                      −0.35 (−0.52 to −0.18)   −0.11 (−0.27 to 0.06)    −0.42 (−0.64 to −0.20)   −0.21 (−0.45 to 0.03)    0.56 (0.34 to 0.79)
  Switzerland   60                      1.79 (1.66 to 1.91)      0.78 (0.63 to 0.94)      −0.08 (−0.36 to 0.20)    −0.55 (−0.79 to −0.31)   0.91 (0.69 to 1.12)
  Total         1833                                                                                                                        

Factor 1: primary care practitioners' ability to refer {#s3a}
------------------------------------------------------

This factor contained six items. A higher score on this factor indicated lower barriers to specialist referral, more time during the consultation to consider whether the patient needs a referral and absence of criticism from colleagues over referrals that were perceived to be unnecessary. This factor explained 15.5% of the variance of individual responses. A comparison of national scores for factor 1 is shown in [figure 1](#F1){ref-type="fig"}.

![Comparison of national scores for factor 1: primary care practitioner's ability to refer. A higher score indicated lower barriers to specialist referral.](bmjopen-2018-022904f01){#F1}

Factor 2: degree of direct patient access to secondary care {#s3b}
-----------------------------------------------------------

This factor contained six items. A higher score for this factor was linked with items relating to direct patient access to secondary care: the absence of a GP gatekeeping role, with higher financial and geographical barriers to healthcare for some patients, and in some cases the presence of a quota for diagnostic tests. Higher scores for this factor were also linked with less likelihood of having a fast-track specialist appointment system for patients with suspected cancer. Factor 2 explained 10.8% of the variance of individual responses, and the comparison of national scores for this factor is shown in [figure 2](#F2){ref-type="fig"}.

![Comparison of national scores for factor 2: degree of direct patient access to secondary care. A higher score was linked with the absence of a general practitioner gate-keeping role, but higher financial and geographical barriers to healthcare for some patients.](bmjopen-2018-022904f02){#F2}

Factor 3: primary care practitioners' perceptions of being under pressure {#s3c}
-------------------------------------------------------------------------

This factor contained four items. A higher score was linked with perceptions of pressure on the PCP from a high workload, as well as demands from patients, the public and the health system. It explained 7.6% of the variance of individual responses. A comparison of national scores for factor 3 is shown in [figure 3](#F3){ref-type="fig"}.

![Comparison of national scores for factor 3: pressure on primary care practitioners from outside. A higher score was linked with perceptions of higher pressure on the primary care practitioner.](bmjopen-2018-022904f03){#F3}

Factor 4: expectations of the primary care practitioners' role {#s3d}
--------------------------------------------------------------

This factor contained two items. A higher score for this factor was associated with higher expectations of PCP-centred care, and the presence of guidelines to support PCP decision-making. It explained 6.7% of the variance of individual responses, and a comparison of national scores for this factor is shown in [figure 4](#F4){ref-type="fig"}.

![Comparison of national scores for factor 4: expectations of the primary care practitioner's (PCPs\') role. A higher score was associated with higher expectations of PCP-centred care, and the presence of guidelines to support PCP decision-making.](bmjopen-2018-022904f04){#F4}

Factor 5: quality before cost {#s3e}
-----------------------------

This factor contained two items. A higher score was linked with PCP perceptions that in their systems high quality care for patients was more important than costs, and that financial aspects had less effect on their referral decision-making. This factor explained 6.4% of the variance of individual responses. A comparison of national scores for factor 5 is shown in [figure 5](#F5){ref-type="fig"}.

![Comparison of national scores for factor 5: quality before cost. A higher score was linked with primary care practitioner perceptions that in their systems high quality care for patients was more important than costs.](bmjopen-2018-022904f05){#F5}

Sensitivity analysis {#s3f}
--------------------

In a sensitivity analysis with weighting of the responses to adjust for the differing numbers of respondents per country, only one statement moved to a different factor: the statement \"In my practice, patients often have to travel a long way to see a specialist\" moved from factor 2 to factor 4.

Discussion {#s4}
==========

Principal findings {#s4a}
------------------

Based on a content validity process, a 45-item pool on referral decision-making for patients who could have cancer was reduced to a 20-item questionnaire. From the responses of 1830 PCPs, from 25 primary care centres in 20 European countries, 5 key factors were identified: PCPs' ability to refer; degree of direct patient access to secondary care; PCP perceptions of being under pressure; expectations of the PCPs' role; and the extent to which PCPs believe that, in their systems, quality comes before cost. The factors showed significant variation between the participant countries.

Interpretation of the results {#s4b}
-----------------------------

Based on the content validity and the significant variation between countries, the survey can be regarded as relevant for studying aspects of PCPs' perceptions of what affects their referral and investigation of patients with symptoms that could be due to cancer. Thus, the developed questionnaire could be used in further research to evaluate associations with cancer outcomes, and could also be used to evaluate changes in healthcare systems regarding referring patients who could have cancer.

Factor 1. PCPs' ability to refer: the variation in PCPs' ability to refer was linked to structural differences like barriers to specialist referrals (including waiting times), the degree of criticism of PCPs relating to their referrals, the quality of relationships between PCPs and specialists and the length of the PCPs' consultations with patients. This was the most important factor, carrying most of the explained variation, and consequently it appears to be particularly important in explaining between-country differences in primary care cancer diagnosis.

Factor 2. Degree of direct patient access to secondary care: this important factor was related to the extent to which GPs were gatekeepers and to which public systems provided universal access to healthcare, whether self-referral to specialists was possible outside the public health system, patients' ability to travel to and fund specialist consultations and whether fast-track referral systems were in place for patients with suspected cancer.

Factor 3. PCPs' perceptions of being under pressure: variations in PCPs\' perceptions of being under pressure were linked with PCP workloads, patient expectations and their level of trust in their doctors and the extent to which health systems expected PCPs to refer patients.

Factor 4. Expectations of the PCPs' role: differing expectations of the PCPs' role were related to whether there had been a shift of work and responsibility between secondary and primary care, and the extent to which patient care was from specialists rather than from PCPs.

Factor 5. Quality before cost: the variation in the extent to which PCPs perceived the balance between quality of care and cost was linked with how much PCPs themselves were directly affected by considerations of cost.

Strengths and weaknesses of the study {#s4c}
-------------------------------------

There were participating centres in four countries from each of the Central, Eastern, Northern, Southern and Western European geographical areas, providing variation in geography, health systems and levels of healthcare spending. It included the views of PCPs who are not usually involved in research. The questionnaire was carefully developed and piloted by GPs and other PCPs, and therefore grounded in their clinical experience. The sensitivity analysis suggested that the factor structure is robust and not driven by countries with larger numbers of respondents.

While low survey response rates are common in primary care[@R35] and are known to vary between countries, the response rates in our study were comparable to those of a recent ICBP survey, in which response rates varied from 5.5% to 45.6%.[@R26] As the survey was anonymous, we have no data on non-responders. It is possible that the PCPs with the most interest in this subject were the most likely to respond. However, while this selection bias may have affected the factor loadings, it is unlikely to have changed the factor structure itself.

While the demographic data that we collected included the gender of participants and the number of years that they had been in practice, we have found no equivalent data on national PCP populations that would allow us to assess how representative our samples were.

Most samples were taken from each local lead's own locality, and these may not have been representative of their nations as a whole.[@R36] While this makes it difficult to generalise the findings to each country, the variation between countries is relevant and valid. The recruitment method used in this study resulted in variable response rates, leading to a risk of non-response bias and loss of power.[@R35] However, the goal of 50 survey participants per centre and \>1000 respondents in total was achieved.

Participants' responses may have been influenced by previous questions, and there may have been country-level differences in response styles, for instance, choosing or avoiding the 'extreme' options on the scale.[@R37] As the translation also included a cultural adaptation we believe this bias was minimised, and the differences between countries cannot simply be explained by differences in response styles.

The five factors accounted for 47.4% of the variance in PCPs' responses, and it is acceptable to consider a solution that accounts for 60% or less of the total variance as satisfactory.[@R38] Two of the factors only included two items each, which makes them vulnerable to missing responses and stochastic variation.

Comparison with other studies {#s4d}
-----------------------------

To our knowledge, this is the first study that has been designed to identify the factors underlying PCPs' referral decision-making, and provide international comparisons of the extent to which PCPs themselves perceive these as important. An ICBP narrative review compared the characteristics of healthcare systems of six countries (Australia, Canada, Denmark, Norway, Sweden and the UK), aiming to identify characteristics that could possibly modify the diagnostic pathway.[@R39] However, unlike our study, it only explored the systems of relatively wealthy countries, and it did not examine PCPs' own perceptions of how their systems affected their decision-making. Our finding that PCPs in different European countries perceive different levels of access to investigations and specialist opinions may be relevant to the finding of varying referral delays in three European countries (Scotland, the Netherlands and Sweden).[@R40]

Possible implications for clinicians and policymakers {#s4e}
-----------------------------------------------------

Five health system factors were able to explain nearly half of the variation in the PCPs' responses to the items. This indicates that a relatively large part of the variation may be explained by differences between the health systems. Our study indicates the policy domains where countries might be able to modify their systems to better support their GPs and other PCPs in the timely referral and investigation of patients who could have cancer.

The most important of these factors were the ease of PCPs' ability to refer, and the degree of direct patient access to secondary care. These factors are key in supporting earlier and expedited cancer diagnosis and may thus be linked with cancer outcomes. It therefore seems plausible that some countries could improve their cancer outcomes by providing better access to investigations and secondary care when cancer is suspected.

Unanswered questions and future research {#s4f}
----------------------------------------

The five factors and their related scores should be compared with national cancer outcomes. These outcomes could include mortality, stage distribution and patient evaluations. An additional area of study could be to relate the factors and scores to national health system costs.

Conclusions {#s5}
===========

This research has developed a 20-item questionnaire with good content and construct validity, and has identified five factors that PCPs perceive to affect their referral decision-making in patients that could have cancer. These appear to vary depending on the different European models of primary care. This understanding of the interaction between health system variables and PCP decision-making can help in an exploration of the differences in national cancer diagnostic pathways and cancer outcomes, and could help to inform health service policy and research towards better cancer outcomes.
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